(E) 501-600 Flashcards
1
Q
- ALUM HEMATOXYLIN: recommended for progressive staining but can also be used for regressive staining
- IRON HEMATOXYLIN: used only for differential or regressive staining
- COPPER HEMATOXYLIN: study of spermatogenesis
A
- Stain for reticulin fibers: GOMORI’S SILVER IMPREGNATION STAIN
- Stain for basement membrane: PAS, AZOCARMINE
- Stain for muscle striations: MALLORY’S PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH)
- Stain for melanin and argentaffin granules: MASSON-FONTANA
- Stain for calcium: VON KOSSA
2
Q
- To avoid distortion of the image, the REFRACTIVE INDEX OF THE MOUNTANT should be as near as possible to that of the glass which is 1.518
A
- Staining method of choice for exfoliative cytology: STILL THE ORIGINAL PAPANICOLAU (PAP’S)
3
Q
- ADENOMAS: benign tumors arising from glands
- POLYPS OR PAPILLOMAS: benign tumors from epithelial surfaces
A
- CARCINOMA: malignant tumor of EPITHELIAL ORIGIN
- SARCOMA: malignant tumor of CONNECTIVE TISSUE (MESENCHYMAL) ORIGIN
4
Q
- REPORTING FOR DIAGNOSIS OF CANCER (PAP’S)
CLASS I: Absence atypical or abnormal cells
CLASS II: Atypical cytological picture but no evidence of malignancy
CLASS III: Cytologic picture suggestive but not conclusive of malignancy
CLASS IV: Cytologic picture strongly suggestive of malignancy
CLASS V: Cytologic picture conclusive of malignancy
A
- APLASIA: incomplete or defective development of a tissue or organ, represented only by a mass of fatty or fibrous tissue,
- HYPOPLASIA: failure of an organ to reach or achieve its full mature or adult side due to incomplete development
5
Q
- AGENESIA: complete non-appearance of an organ
- ATRESIA: failure of an organ to form an opening
A
- ATROPHY: acquired decrease in size of a normally developed or mature tissue or organ resulting from reduction in cell size or decrease in total number of cells or both
6
Q
- COAGULATION NECROSIS: It is most commonly encountered when the arterial supply is cut off producing ANEMIC or ISCHEMIC INFARCTION
A
- LIQUEFACTION NECROSIS (COLLIQUATIVE): Rapid total enzymatic dissolution of cells with complete destruction of the entire cell; most commonly encountered in the brain; also in all tissues in bacterial infections which lead to the formation of pus
7
Q
- FAT NECROSIS: Peculiar destruction of adipose tissue, particularly found in pancreatic degenerations
- CASEOUS NECROSIS: Special form of cell death by the Tubercle Bacillus, the destroyed cells are converted into a granular, friable mass made up of a mixture of coagulated protein and fat, with total loss of cell detail. Caseous necrosis because in the gross state, the necrotic tissue has the appearance of soft, friable CHEESE.
A
- GANGRENOUS NECROSIS: Massive death or necrosis of tissue, caused by combination of ischemia and superimposed bacterial infection (necrosis plus putrefaction).
8
Q
- PRIMARY CHANGES OR SIGNS OF DEATH
CIRCULATORY FAILURE
RESPIRATORY FAILURE
NERVOUS FAILURE
A
- SECONDARY SIGNS OF DEATH:
ALGOR MORTIS – first demonstrable change, cooling of the body, occurring at definite rate of about 7F per hour
RIGOR MORTIS – rigidity or stiffening of the muscles occurring about 6 to 12 hours after death and persisting for 3 to 4 days
LIVOR MORTIS – purplish discoloration of the body
POSTMORTEM CLOTTING – immediately after death, rubbery consistency (must differentiate from antemortem clot – before death, friable)
DESICCATION – drying and wrinkling of the cornea and anterior chamber of eye due to absorption of the aqueous humor
PUTREFACTION – production of foul-smelling gases due to invasion of the tissue by saprophytic organism
AUTOLYSIS – self-digestion of cells
9
Q
- Conversion factor, thyroxine (µg/dL to nmol/L): 12.9
- Conversion factor, immunoglobulin (mg/dL to g/L): 0.01
- Conversion factor, immunoglobulin (mg/dL to mg/L): 10
A
- Without error, closeness to the true value: ACCURACY
- The closeness of repeated results; quantitatively expressed as standard deviation or coefficient of variation: PRECISION
10
Q
- Point where most values lie: MODE
- Figure for which 50% of the values are higher and 50% of the values are lower: MEDIAN
A
- Ability of an analytical method to measure the smallest concentration of the analyte of interest: ANALYTICAL SENSITIVITY
- Ability of an analytical method to measure only the analyte of interest: ANALYTICAL SPECIFICITY
11
Q
- Values for the control that continue to either increase or decrease over a period of six consecutive days: TREND
A
- Six or more consecutive daily values that distribute themselves on one side of the mean value line, but maintain a constant level: SHIFT
12
Q
- System or process that encompasses (in the laboratory) PRE-ANALYTIC, ANALYTIC, AND POST-ANALYTIC FACTORS. Quality control is part of a quality-assurance system: QUALITY ASSURANCE (QUALITY ASSESSMENT)
A
- System for recognizing and minimizing (analytic) errors. The purpose of the quality-control system is to monitor analytic processes, detect analytic errors during analysis, and prevent the reporting of incorrect patient values. Quality control is one component of the quality-assurance system: QUALITY CONTROL
13
Q
AMPLIFICATION
Technique to ↑ (amplify) amount of nucleic acid in sample, probe, or signal so that very small amounts of nucleic acid can be detected.
———————
1. TARGET AMPLIFICATION
Technique to ↑ amount of target nucleic acid in sample through in vitro replication, e.g., polymerase chain reaction (PCR), transcription mediated amplification (TMA).
———————
A
- SIGNAL AMPLIFICATION
Technique to ↑ signal generated so that very small amounts of nucleic acid can be detected, e.g., branched chain signal amplification (bDNA), hybrid capture assay (HCA).
——————— - PROBE AMPLIFICATION
Technique to ↑ amount of probe bound to target so very small amounts of nucleic acid can be detected, e.g., ligase chain reaction.
14
Q
- Used to determine whether there is a statistically significant difference between the means of two groups of data. (accuracy, mean): T-TEST
A
- Statistical test used to compare features of two or more groups of data (SD, precision): F-TEST
15
Q
- Early morning before the patient has eaten or become physically active. This is a good time to draw blood specimens because the body is at rest and food has not been ingested during the night: BASAL STATE
A
- Records each step and each person who handled a sample (for toxicological analysis) from time of collection to time of analysis: CHAIN-OF-CUSTODY
16
Q
- An algorithm in which the most recent result of a patient is compared with previously determined value: DELTA CHECK
- Analytical testing of patient specimens performed outside the physical laboratory and at the site of patient care: POINT-OF-CARE TESTING (POCT)
A
- Mathematically establishes the relationship between concentration and absorbance in photometric determinations; expressed as A = abc: BEER’S LAW